# The Efficacy of Silymarin on the Prevention of Hepatotoxicity From Antituberculosis Drugs

> **NCT01800487** · NA · COMPLETED · sponsor: **Ramathibodi Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** silymarin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01800487
- **Lead sponsor:** Ramathibodi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-06
- **Final completion:** 2013-07
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2013-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01800487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01800487, "The Efficacy of Silymarin on the Prevention of Hepatotoxicity From Antituberculosis Drugs". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01800487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*